Frontiers in oncology.

The Urologic Oncology section of Frontiers in Urology publishes high-quality fundamental clinical and translational research, as well as, in-depth reviews across the field of urologic oncology. This section covers the areas including, but not limited to: - Renal cell carcinoma and other renal pathology - Prostate cancer - Bladder cancerAug 18, 2020 · Chronic Stress Promotes Cancer Development. Stress is an inevitable part of life. Chronic stress on account of reasons like adversity, depression, anxiety, or loneliness/social isolation can endanger human health. Recent studies have shown that chronic stress can induce tumorigenesis and promote cancer development. Safeguarding peer review to ensure quality at scale. Making scientific research open has never been more important. But for research to be trusted, it must be of the highest quality. Facing an industry-wide rise in fraudulent science, Frontiers has increased its focus on safeguarding quality. PRESS RELEASE.How we publish. Frontiers' approach to publishing is driven by the principle of placing publishing back into the hands of researchers, enabled by scalable technology. This means we distribute editorial responsibility to the editorial board who take acceptance or rejection decisions and have the independence to shape the direction of research.

Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Explores research into the molecular and cellular mechanisms of carcinogenesis and cancer progression.Mohamed Rahouma. Massimo Baudo. Magdy M. El-Sayed Ahmed. Frontiers in Oncology. doi 10.3389/fonc.2023.1271452. 776 views. Part of a forward-thinking journal, this section covers the entire emerging interface between cardiovascular medicine and oncology.

Title proper: Frontiers in oncology. Abbreviated key-title: Front. oncol. Original alphabet of title: Basic roman. Publisher: Lausanne: Frontiers Media S.A., 2011- Dates of …Survival of 48866 cancer patients: results from Nantong area, China. Objective: This study aimed to provide a realistic observation of survival by major site for 48,866 cancer patients treated at a tertiary cancer hospital in a rural area of China. Methods: Patients with cancer registered between 2007 and 2017 in the Nantong rural …

Description. Frontiers in Oncology publishes articles on the most outstanding discoveries across the entire research spectrum of Oncology. The mission of Frontiers in Oncology is to bring all relevant Specialties in Oncology together on a single platform. Frontiers in Oncology is composed of the following Specialty Sections: Frontiers in Cancer ...Hepatobiliary Surgeons; Colorectal Surgeons; Transplant Surgeons; Medical Oncologists; Radiation Oncologists; Interventional Radiologists; Radiation Therapists ...Editorial: Novel targets for ovarian cancer stem cells. Although ovarian cancer (OC) has been considered as a chemo-sensitive tumor type, the majority of patients develop chemoresistance, which drives tumor relapse within two years. Cumulative evidence supports that the presence of cancer stem cells (CSCs), in tumor residuals are …Jan 23, 2024 · 3 Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Providence, RI, United States. Editorial on the Research Topic. Expert opinions in genitourinary oncology. In the last decade we have seen an explosion in the development of new treatment options, diagnostic tools, and prognostic and predictive ... SLAS Discovery (2018) 23 (6):574–84. doi: 10.1177/2472555218766842. Keywords: organoids, precision medicine, treatment response, treatment prediction, cancer, patient-derived. Citation: Verduin M, Hoeben A, De Ruysscher D and Vooijs M (2021) Patient-Derived Cancer Organoids as Predictors of Treatment Response.

Figure 1 Hierarchical divisive clustering of brain tumor patients, based on the collected features. The dendrogram reporting the clusters identified through divisive hierarchical clustering is reported. Gower distance is reported on the y axis and each single unit analyzed (i.e. patients) on the x axis.

See all (43) Learn more about Research Topics. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes.

mohammad athar. University of Alabama at Birmingham. Birmingham, United States. Specialty Chief Editor. Skin Cancer. michael kattan. Cleveland Clinic Lerner College of Medicine, School of Medicine, Case Western Reserve University. Cleveland, United States. Specialty Chief Editor. Genitourinary Oncology. Epigenetic and Metabolic Regulators of Breast Carcinogenesis. Iman Mamdouh Talaat. Maha Mohamed Saber-Ayad. Hauke Busch. Noha Mousaad Elemam. 21,657 views. 14 articles. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of …Nevertheless, according to the Associazione Italiana di Oncologia Medica (AIOM), the European Society for Medical Oncology (ESMO), and the National Comprehensive Cancer Network ® (NCCN) guidelines, neoadjuvant chemotherapy is an established treatment that improves oncological outcomes in locally advanced …Many modern immunotherapies focus on blood-based cancers, like the leukemias and lymphomas that ONO researcher's study, but solid tumours could also benefit ...The AA of oncology drugs is traditionally supported by single-arm trials. The emphasis on randomization and control fits the 2-in-1 design well because it is the default feature of any adaptive phase 2/3 trial. Project FrontRunner also proposed a one-trial approach to support both AA and regular approval (RA) in the same phase 3 trial, on top ...

penelope jayne duerksen-hughes. Loma Linda University. Loma Linda, United States. Associate Editor. Gynecological Oncology. Part of a multidisciplinary journal, this section explores the development of a personalized and tailored approach to the prevention and treatment of gynecologic malignancies.Terms and conditions. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.Frontiers requires manuscripts submitted to meet international English language standards to be considered for publication. For authors who would like their manuscript to receive language editing or proofreading to improve the clarity of the manuscript and help highlight their research, we recommend the language-editing services provided by the following external partners.Artificial Intelligence (AI) has many possible applications in Oncology. One of the most promising is the potential for AI to represent and/or infer processes from real-world data. On one hand, the availability of the pattern of care is growing in opportunities (e.g. new markers, devices, drugs, etc.), constraints (guidelines, protocols, legal issues), and needs (e.g. investments, sustainable ...brian jensen. School of Medicine, University of North Carolina at Chapel Hill. Chapel Hill, United States. Associate Editor. Cardio-Oncology. Part of a forward-thinking journal, this section covers the entire emerging interface between …Minimally Invasive Therapies and Molecular Mechanisms Related to Recurrence in Hepatobiliary and Gastric Cancers. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of hepato pancreatic biliary neoplasia.

Jing Yang. Xin Li. Rong-Xia Huang. Jian Chen. Frontiers in Oncology. doi 10.3389/fonc.2024.1377486. 161 views. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.

Pediatric Oncology. sergi aranda. National Center for Genomic Analysis, Center for Genomic Regulation (CRG) Barcelona, Spain. Associate Editor. Pediatric Oncology. nicoleta arva. Feinberg School of Medicine, Northwestern University. …See all (158) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores all aspects of hematological malignancies, including acute and chronic leukemia, lymphoma and plasma and hematopoietic stem cell disorders.Introduction. It has been estimated that breast cancer surpassed lung cancer as the first cause of global cancer incidence in females, with 2,261,419 new cases in 2020 ().Moreover, breast cancer is the fifth leading cause of cancer death in females and also a considerable cause of cancer death in males worldwide (1, 2).The incidence rate …Scope. This section of the journal will focus on the basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells. This broadly includes mitochondrial, glycolytic, fatty acid, as well as other forms of metabolism.Advances in Clinical Sarcoma Research: Quality of Life in Sarcoma Patients. Alexander Klein. Dimosthenis Andreou. Dorit Di Gioia. 1,876 views. 2 articles. Advances understanding of new diagnostic and therapeutic strategies of surgical relevance that demonstrably impact cancer patient outcomes.Mar 18, 2022 ... Nutrition Frontiers - Winter 2022 ... This issue of Nutrition Frontiers showcases gut permeability with calcium and/or vitamin D3, microRNAs role ... Frontiers requires figures to be submitted individually, in the same order as they are referred to in the manuscript; the figures will then be automatically embedded at the end of the submitted manuscript. Kindly ensure that each figure is mentioned in the text and in numerical order.

Mar 30, 2017 ... Synthetic biology promises to revolutionize cancer care by offering permanent cures to patients with historically untreatable malignancies.

See all (158) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores all aspects of hematological malignancies, including acute and chronic leukemia, lymphoma and plasma and hematopoietic stem cell disorders.

francesco giovinazzo. Unit of General and Liver Transplant Surgery, Department of Medical and Surgical Sciences, Agostino Gemelli University Polyclinic (IRCCS) Rome, Italy. Specialty Chief Editor. Surgical Oncology.May 10, 2024 · This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment. Frontiers in Oncology publishes high-quality research on all aspects of cancer, from basic science to clinical applications. It has a fast and rigorous peer review process, a high impact factor and cite score, and a large network of editors and reviewers.If you’re in the market for a reliable and versatile off-road vehicle, then look no further than the Nissan Frontier 4×4. With its rugged design, powerful performance, and advanced...Frontiers in Oncology publishes rigorously peer-reviewed research across the entire field of cancer research. Field Chief Editor Giuseppe Giaccone at Georgetown University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and …Our vision for the program is Comprehensive Cancer Care and Optimized Cancer Survival by 2025. We hope to achieve the vision of our country, that is, the ...The Cancer Imaging and Image-directed Interventions Section is dedicated to the publication of results from clinical and research imaging studies applied to cancer discovery, diagnosis, and treatment. The section will accept studies from the entire field of cancer imaging: results from the routine use of clinical imaging in both radiology and ...Introduction. Glioma is the most common neuroepithelial tumor of the cerebral nervous system ().Ki-67 labeling index (LI) is a nuclear antigen expressed only by proliferating cells ().Previous studies showed that Ki-67 LI was one of the vital biological behavior biomarkers in glioma and correlated with glioma grading and prognosis (3, …The Urologic Oncology section of Frontiers in Urology publishes high-quality fundamental clinical and translational research, as well as, in-depth reviews across the field of urologic oncology. This section covers the areas including, but not limited to: - Renal cell carcinoma and other renal pathology - Prostate cancer - Bladder cancerFemale breast cancer (BC) has surpassed lung cancer and today it is the most diagnosed type of cancer (2.3 million new cancer cases, representing 11.7% of all cancer cases). In terms of mortality, it ranks in 5 th place, with 685,000 deaths in 2020. For women, BC represents 1 in 4 cancer cases and accounts for 1 in 6 cancer deaths ( 1 ).

Frontiers in Oncology is an open access journal that covers all areas of cancer research, from epidemiology to therapeutics. It is led by Field Chief Editor Prof Giuseppe Giaccone and publishes original research, reviews, and perspectives in various specialty sections. Advances in Clinical Sarcoma Research: Quality of Life in Sarcoma Patients. Alexander Klein. Dimosthenis Andreou. Dorit Di Gioia. 1,876 views. 2 articles. Advances understanding of new diagnostic and therapeutic strategies of surgical relevance that demonstrably impact cancer patient outcomes.weixing dai. Shanghai Cancer Center, Fudan University. Shanghai, China. Associate Editor. Gastrointestinal Cancers: Colorectal Cancer. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of colorectal neoplasia.Instagram:https://instagram. virtual animalshyde park restaurantslax to irelandwebtoons comics In Vitro Peptide Re-Stimulation (IVS) of the Murine Splenocytes. Fresh splenocytes isolated from vaccinated animals were stimulated with either HAGE 30-mer long peptides, WT1 15-mer long peptides or both, at a concentration of 1μg/mL in the presence of β-mercaptoethanol and 50U/mL mIL-2 for 7 days at 37°C in a 5% (v/v) CO 2 incubator. best plant identification appsheets multiply Frontiers operates a single-blind model during the review process. This means the reviewers know who the authors are in order to offer a full assessment within the context of their research and to ensure they can avoid any potential competing interests in accepting a review invitation. Frontiers also believes that reviewers should be ...Jul 4, 2022 · 1 Cancer Research Center for Health Equity, Division of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, United States; 2 Norris Comprehensive Cancer Center, University of Southern California, Keck School of Medicine, Los Angeles, CA, United States universal world singapore Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, clinicians, and public health … Frontiers requires manuscripts submitted to meet international English language standards to be considered for publication. For authors who would like their manuscript to receive language editing or proofreading to improve the clarity of the manuscript and help highlight their research, we recommend the language-editing services provided by the following external partners. Radiotherapy for Esophageal Cancer: Molecular Mechanism and Novel Targets to Improve Radiosensitivity. Xiaodong Li. Yanqing Liu. Adam Yongxin Ye. Xiao Zheng. 7,350 views. 6 articles. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of gastric and ...